Best Oncologist in India: How to Choose the Right Cancer Specialist

A practical guide to choosing well — how cancer care is organised, the three types of oncologist and their subspecialties, how to judge credentials, the mistakes to avoid, and verified specialists at India's leading hospitals.

Quick Answer
  1. 1

    There is no single "best oncologist" in India — cancer is treated by three specialists (medical, surgical and radiation) whose plan is agreed by a multidisciplinary tumour board.

  2. 2

    Treatment in India typically costs far less than in the US, UK or the Gulf, at JCI- and NABH-accredited hospitals.

  3. 3

    The right specialist depends on your cancer type and stage — many patients need more than one, working as a team.

  4. 4

    You can get a free written second opinion from an Indian oncologist before you travel.

  • Choose a high-volume specialist with a DM, MCh or DrNB super-specialty qualification.
  • For surgery, match your cancer to a subspecialist (breast, head & neck, GI, thoracic, gynaecologic).
  • Verify any doctor on India's National Medical Commission register.

Explore best hospitals in detail below.

Search for the "best oncologist in India" and you'll find ranked lists of famous names. But cancer care doesn't work that way. The doctor who is right for an early-stage breast cancer is rarely the right choice for an advanced lung cancer, and almost no serious cancer is treated by one doctor alone.

This guide is built to help you choose well, not just recognise a name. It explains how cancer care is organised, the three types of oncologist and their subspecialties, exactly how to judge a specialist, the mistakes to avoid, and the questions to ask — followed by verified specialists across India's leading hospitals.

Cancer Is Treated by a Team, Not One Doctor

Modern cancer care is a team effort. At a serious centre, your diagnosis is discussed by a multidisciplinary tumour board — the surgical, medical and radiation oncologists, with a radiologist and pathologist — who agree one plan rather than each deciding alone.

This matters more than the fame of any individual. A tumour board catches what a single doctor might miss, sequences treatment correctly (for example, chemotherapy before or after surgery), and tailors the plan to your exact cancer, stage and health.

The most useful question you can ask any centre is simply whether your case will go to a tumour board. If the answer is vague, that tells you something.

The Three Types of Oncologist

Almost every cancer is treated by one or more of three specialists:

  • Medical oncologist — leads the drug treatment of cancer: chemotherapy, targeted therapy, immunotherapy and hormone therapy. Often coordinates the plan and manages advanced disease.
  • Surgical oncologist — removes the cancer, with affected tissue or lymph nodes. Leads for operable, early-stage disease, increasingly using minimally invasive and robotic techniques.
  • Radiation oncologist — uses precisely targeted radiotherapy to destroy cancer cells or reduce the risk of recurrence, often alongside surgery or drug therapy.

For many cancers these roles combine, and the order in which they happen is part of the plan.

Subspecialties: Why "Best" Depends on Your Cancer

Within each type, the strongest specialists subspecialise. A surgeon who operates on the same cancer every week builds deeper expertise than a generalist — and for many cancers, the completeness of that surgery is one of the strongest influences on the outcome.

Common surgical subspecialties include breast, head and neck, gastrointestinal and hepatobiliary (GI & HPB), thoracic (lung), gynaecologic, urologic and musculoskeletal cancers. Medical oncology includes haemato-oncology (blood cancers) as a distinct field. Radiation oncology spans techniques such as IMRT, IGRT, SBRT and brachytherapy, and — at select centres — proton therapy.

The practical takeaway: don't look for "the best oncologist" in the abstract. Look for the best specialist for your specific cancer.

Match the specialist to the job
You don't choose "the best oncologist" in general — you choose the right type, and the right subspecialist, for your exact cancer and stage. Starting with a generalist when your case needs a dedicated specialist is one of the most common and costly mistakes a patient can make.

How to Judge an Oncologist in India

Every credential can be checked, and experience with your exact cancer matters more than general fame. Look for four things:

  • Super-specialty qualifications — DM or DrNB (medical oncology), MCh or DrNB (surgical oncology), MD or DNB (radiation oncology). International qualifications such as MRCP, FRCR or ESMO/ECMO fellowships are a plus.
  • Case volume — how many patients with your specific cancer the doctor treats each year.
  • Tumour board — whether your case will be reviewed by a multidisciplinary team.
  • Accreditation — a JCI- or NABH-accredited hospital with the technology your treatment needs.

You can confirm any doctor's registration on India's National Medical Commission register, and find the specialist in the correct department on the hospital's own website.

Ask whether your case goes to a tumour board
The single strongest sign of a serious cancer centre is that your case is discussed by a multidisciplinary tumour board — surgeon, medical and radiation oncologists, radiologist and pathologist agreeing one plan together, rather than one doctor deciding alone.

Mistakes to Avoid When Choosing an Oncologist

A few common errors cost patients time, money and sometimes outcomes:

  • Starting with a generalist when your cancer needs a subspecialist surgeon or a specific type of oncologist.
  • Skipping the second opinion — a written review of your reports before you commit often changes the plan.
  • Choosing by fame alone — reputation is not the same as high volume in your exact cancer.
  • Not asking about the tumour board — single-doctor decisions are a warning sign at any serious centre.
  • Forgetting fertility — if it matters to you, preservation must be arranged before treatment starts, never after.

Questions to Ask Any Oncologist

Bring these to your first consultation or remote opinion:

  • What is my exact diagnosis, type and stage?
  • Which specialists will be involved, and will my case go to a tumour board?
  • What is the goal of treatment, and what are the options?
  • In what order will treatment happen, and why?
  • How many patients with my cancer do you treat each year?
  • What are the risks, side effects and expected recovery?
  • What will it cost, in writing — and what is not included?

Where Cancer Care Is Concentrated in India

India's strongest cancer programmes cluster in a handful of cities, each with accredited, high-volume hospitals:

Choosing a city often comes down to the specialist you need and ease of travel.

Why International Patients Choose India

India treats hundreds of thousands of international cancer patients each year, combining experienced high-volume teams with the lower costs it is known for.

  • Cost — generally far lower than in the US, UK and the Gulf (ask for an itemised estimate).
  • Quality — JCI- and NABH-accredited hospitals; specialists trained at India's top institutes and abroad.
  • Technology — modern radiotherapy (including proton therapy at select centres), robotic surgery and molecular diagnostics.
  • Team care — multidisciplinary tumour boards at established centres.
  • Logistics — an e-Medical Visa on a hospital invitation letter; English-speaking teams; end-to-end coordination.

Your Journey as an International Patient

Most of the journey starts before you travel:

  1. Send reports — share your biopsy, scans and reports for a free remote second opinion.
  2. Get a plan — the right specialist returns a written plan and an itemised cost.
  3. Visa — on a hospital invitation letter, you receive an e-Medical Visa.
  4. Treatment — you travel for treatment at an accredited hospital.
  5. Follow-up home — you return with records and a shared-care plan, with teleconsultation follow-up.

Related Doctors

24 doctor
Dr. Harit Kumar Chaturvedi
Dr. Harit Kumar Chaturvedi

Chief Executive Officer & Clinical Head — Surgical Oncology

Surgical Oncologist

Breast CancerHead and Neck CancerOral Cancer
New Delhi, IndiaIndraprastha Apollo Hospital

32+ years of experience

Dr. Harit Kumar Chaturvedi is Chief Executive Officer and Clinical Head of Surgical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 32 years of dedicated experience to the field of cancer surgery. He holds an M.Ch in Surgical Oncology from AIIMS New Delhi and completed his fellowship at Tata Memorial Hospital, Mumbai—credentials that establish him as one of India's most respected surgical oncologists. His clinical journey has been defined by a commitment to precision, innovation, and comprehensive cancer care across multiple organ systems. Dr. Chaturvedi's clinical portfolio spans the full spectrum of surgical oncology, including breast cancer, head and neck malignancies, lung, gastric, colorectal, pancreatic, renal, bladder, and esophageal cancers. He is a pioneer in robotic-assisted surgical oncology across South Asia, proficient in the da Vinci Xi robotic systems, and performs advanced procedures including cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). His high-volume practice and mastery of both open and minimally invasive techniques enable him to offer individualized treatment plans tailored to each patient's cancer stage and overall health. International patients form a significant part of Dr. Chaturvedi's practice. He regularly treats patients from the Middle East, SAARC nations, CIS countries, and Africa, offering them access to world-class cancer care with the reassurance of fluent English communication, transparent treatment planning, and a patient-centric approach. Many international patients value his shared decision-making model, which ensures clarity at every stage of care and empowers patients to participate actively in their treatment journey. Indraprastha Apollo Hospital, where Dr. Chaturvedi leads the surgical oncology division, is a NABH and JCI-accredited institution equipped with state-of-the-art robotic surgical suites, advanced imaging, and dedicated intensive care facilities. The hospital's international patient services team facilitates visa assistance, accommodation coordination, and seamless follow-up care, making it an ideal destination for overseas patients seeking complex cancer surgery. Dr. Chaturvedi's leadership and his hospital's infrastructure combine to offer international patients the confidence that they are receiving treatment at par with leading global oncology centers. For patients seeking a surgical oncologist with deep expertise, international exposure, and a genuine commitment to shared decision-making, Dr. Chaturvedi represents the caliber of care that has established India as a leading destination for cancer surgery. His 32+ years of experience, combined with his mastery of cutting-edge surgical techniques and his recognition within major Indian and international oncology societies, ensure that international patients receive evidence-based, compassionate care aligned with global best practices.

Dr. Ankur Bahl
Dr. Ankur Bahl

Principal Director — Medical Oncology

Medical Oncologist

Breast CancerLung CancerHead and Neck Cancer
Gurugram, IndiaFortis Memorial Research Institute

17+ years of experience

Dr. Ankur Bahl is the Principal Director of Medical Oncology at Fortis Memorial Research Institute in Gurugram, bringing over 17 years of specialised clinical experience in cancer treatment. A graduate of Maulana Azad Medical College, Delhi, where he completed both his MBBS and MD in Medicine, Dr. Bahl furthered his expertise by obtaining his DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. He has also completed a specialized course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK, strengthening his evidence-based approach to cancer care. Dr. Bahl's clinical depth encompasses the full spectrum of medical oncology, including chemotherapy for solid tumours, neoadjuvant and adjuvant chemotherapy protocols, immunotherapy using immune checkpoint inhibitors, targeted molecular therapies, and hormonal treatment for breast cancer. He is recognised as the lead author of the largest real-world Indian dataset on targeted therapy with Cetuximab in head and neck cancer, acute myeloid leukaemia treatment, and Human Papillomavirus epidemiology in the Indian population—publications that have shaped understanding of cancer patterns and treatment efficacy in the region. His commitment to evidence-based oncology is evident through his active participation in tumour boards, master classes, and workshops across India and internationally. Dr. Bahl treats a substantial international patient cohort, welcoming patients from the Gulf Cooperation Council states, African nations, and South Asian countries seeking advanced oncological care. His fluency in English and Hindi enables seamless communication with diverse patient backgrounds. He provides comprehensive supportive and palliative care alongside curative treatments, ensuring patients receive holistic management throughout their cancer journey. Fortis Memorial Research Institute, where Dr. Bahl practises, is a leading tertiary-care cancer centre in Gurugram with state-of-the-art infrastructure, dedicated oncology wards, advanced diagnostic and treatment facilities, and a strong international patient support team. The hospital maintains accreditation standards and offers integrated care with specialist nurses, nutritionists, and counsellors. International patients benefit from streamlined admission processes, translation services, and coordination of follow-up care. Dr. Bahl's position as Principal Director ensures that patients receive leadership-level oversight of their treatment strategy, with access to the latest clinical protocols and innovations in cancer therapy.

Dr. Vedant Kabra
Dr. Vedant Kabra

Principal Director — Surgical Oncology

Surgical Oncologist

Breast cancerHead and neck cancerGastrointestinal cancers
Gurugram, IndiaFortis Memorial Research Institute

25+ years of experience

Dr. Vedant Kabra is the Principal Director of Surgical Oncology at Fortis Memorial Research Institute, Gurugram. He received Surgical Oncology training from Tata Memorial Hospital, Mumbai and the National Cancer Centre, Singapore. Dr. Kabra has experience of over 12,000 cancer surgeries and has successfully performed various complex onco-surgical procedures including Robotic Surgery for Cancer. He has been a faculty member at various international and national conferences, has numerous papers and three book chapters to his credit, apart from various awards for academic excellence. Dr. Kabra is passionate about spreading cancer awareness through regular health talks, awareness drives and self-examination camps. He is also spearheading the tobacco cessation movement — Voice of Tobacco Victims (VoTV) — in Gurugram and Haryana. His areas of clinical interest include breast cancer surgery with breast conservation and oncoplasty, robotic surgery for cancer, gastrointestinal and gynaecological cancer, head and neck cancer, thoracic cancers, and bone and soft tissue cancers.

Dr. Vinay Samuel Gaikwad
Dr. Vinay Samuel Gaikwad

Director – Surgical Oncology

Surgical Oncologist (GI & HPB)

Stomach (gastric) cancerEsophageal cancerColorectal cancer
Gurugram, IndiaFortis Hospital Manesar

24+ years of experience

Dr. Vinay Samuel Gaikwad is a dynamic and extensively trained surgical oncologist and Robotic & Laparoscopic GI surgeon at Fortis Hospital, Manesar, Gurugram. With over 24 years of rich clinical experience, he has been associated with some of the top hospitals in India, including Tata Memorial Hospital, Mumbai and MSKCC, New York. He completed his Fellowship in GI & HPB Surgical Oncology from Tata Memorial Hospital and his Hepatopancreatobiliary Oncology Training from MSKCC, New York. Dr. Gaikwad is proficient in performing the most advanced cancer surgeries including HIPEC and PIPAC, and has authored several articles for both national and international publications. He also specialises in GI and HPB Surgical Oncology and Peritoneal Surface Oncology. He presently leads a team of organ-based surgical oncologists and has been the first to start a hepatic artery infusion pump chemotherapy programme in India — a pioneering achievement that offers patients with liver-dominant metastatic colorectal cancer a powerful additional treatment option. Dr. Gaikwad is certified in HIPEC from ESSO Hannover, Germany and PIPAC from Tubingen, Germany, and has received training in minimally invasive colorectal surgery from AETF South Korea and upper GI surgery from IRCAD Taiwan. He has been recognised with the Most Trusted Oncologist Award 2023 by ASIA-GCC and the Blackswan Award for Excellence in Healthcare 2023-24 by Asia One.

Dr. Archit Pandit
Dr. Archit Pandit

Director — Surgical Oncology

Surgical Oncologist

Lung cancerEsophageal cancerStomach cancer
New Delhi, IndiaFortis Escorts Heart Institute

15+ years of experience

Dr. Archit Pandit is Director of Surgical Oncology at Fortis Escorts, Okhla Road, New Delhi and is a highly accomplished and skilled surgical oncologist trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. With over 15 years of clinical excellence, he has the distinction of performing more than 10,000 complex surgeries during his career spanning about a decade and a half. Internationally trained, Dr. Pandit has completed fellowships at the National Cancer Center, Tokyo (Japan) in minimally invasive gastroesophageal surgeries, and at Yonsei University Severance Hospital, Seoul (South Korea) in thoracic surgery and lung transplantation. He is also trained in Robotic Surgery at the Galaxy Care Institute, Pune, and underwent Colorectal Cancer Training with the Asian Endoscopic Task Force in Fuji, Japan. Additionally, he has completed courses in Advanced Laparoscopy and Pain & Palliative Medicine at AIIMS, New Delhi. Dr. Pandit has various publications in reputed international & national journals. Dr. Archit Pandit is a Gold Medalist (Best Outgoing MS Surgery, Karnataka, 2008) and has won Best Video Awards at the Indian Cancer Congress (2013) and ACOS (2016).

Frequently Asked Questions

Who is the best oncologist in India?
There is no single "best" oncologist — the right one depends on your cancer type and stage, and many patients need more than one specialist. Look for a super-specialty qualification (DM, MCh or DrNB), a high volume of cases like yours, and whether your case will be reviewed by a multidisciplinary tumour board at an accredited hospital.
What is the difference between a medical, surgical and radiation oncologist?
A medical oncologist treats cancer with drugs — chemotherapy, targeted therapy, immunotherapy and hormone therapy. A surgical oncologist removes the cancer with surgery. A radiation oncologist treats it with precisely targeted radiotherapy. Most patients need more than one, working together as a team.
How do I choose the best oncologist for my cancer?
Start with the type of specialist your cancer needs, then look for a matching subspecialty, a super-specialty qualification, a high volume of cases like yours, and a hospital that runs a multidisciplinary tumour board. Experience with your exact cancer matters more than general fame
Do I really need a multidisciplinary tumour board?
For anything beyond the simplest cases, yes. A tumour board brings the surgeon, medical and radiation oncologists, radiologist and pathologist together to agree one plan. It is one of the strongest markers of a serious cancer centre, so ask specifically whether your case will be discussed by one.
How do I verify an oncologist's qualifications in India?
Find the specialist in the correct department on the hospital's own website, confirm the super-specialty qualification (DM, MCh, DrNB, MD or DNB), and check that the hospital holds NABH or JCI accreditation. Registration can be verified on India's National Medical Commission register.
How much does cancer treatment in India cost, and do I need a visa?
Treatment in India generally costs far less than in the US, UK or the Gulf, though the total depends on your plan — always ask for an itemised written estimate. International patients travel on an e-Medical Visa, granted on a hospital invitation letter and commonly valid around 60 days with multiple entry.
Can I get a remote second opinion before travelling to India?
Yes. Your biopsy, scans and reports can be reviewed remotely by the right Indian oncologist, who returns a written opinion and plan before you book any travel or visa. Through GAF this remote second opinion is free, and it is the sensible first step.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India

Get a Free Medical Opinion

An English-speaking patient coordinator will reach out within 24 hours.